Loading clinical trials...
Loading clinical trials...
This is an open-label study of a new oral drug for advanced stage (IIIB or IV) lung cancer. The cancer must be EITHER bronchoalveolar carcinoma (BAC) type, or if the patient is a never-smoker (less th...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Swedish Medical Center
Collaborators
NCT06312137 · Non Small Cell Lung Cancer
NCT07005128 · Small-cell Lung Cancer, Extensive Stage Small-cell Lung Cancer
NCT01717924 · Signet Ring Cell Gastric Adenocarcinoma
NCT07444437 · Non-Small Cell Lung Cancer
NCT07489716 · Non-Small Cell Lung Cancer
Swedish Cancer Institute
Seattle, Washington
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions